Cited by 190

3D deep learning from CT scans predicts tumor invasiveness of subcentimeter pulmonary adenocarcinomas

Zhao, Wei, Yang, Jiancheng, Sun, Yingli, Li, Cheng, Wu, Weilan, Jin, Liang, Yang, Zhiming, Ni, Bingbing +4 more·2018·Cancer Research

Abstract

Identification of early-stage pulmonary adenocarcinomas before surgery, especially in cases of subcentimeter cancers, would be clinically important and could provide guidance to clinical decision making. In this study, we developed a deep learning system based on 3D convolutional neural networks and multitask learning, which automatically predicts tumor invasiveness, together with 3D nodule segmentation masks. The system processes a 3D nodule-centered patch of preprocessed CT and learns a deep representation of a given nodule without the need for any additional information. A dataset of 651 nodules with manually segmented voxel-wise masks and pathological labels of atypical adenomatous hyperplasia (AAH), adenocarcinomas in situ (AIS), minimally invasive adenocarcinoma (MIA), and invasive pulmonary adenocarcinoma (IA) was used in this study. We trained and validated our deep learning system on 523 nodules and tested its performance on 128 nodules. An observer study with 2 groups of radiologists, 2 senior and 2 junior, was also investigated. We merged AAH and AIS into one single category AAH-AIS, comprising a 3-category classification in our study. The proposed deep learning system achieved better classification performance than the radiologists; in terms of 3-class weighted average F1 score, the model achieved 63.3% while the radiologists achieved 55.6%, 56.6%, 54.3%, and 51.0%, respectively. These results suggest that deep learning methods improve the yield of discriminative results and hold promise in the CADx application domain, which could help doctors work efficiently and facilitate the application of precision medicine. Significance: Machine learning tools are beginning to be implemented for clinical applications. This study represents an important milestone for this emerging technology, which could improve therapy selection for patients with lung cancer.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-18-0696

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, W., Yang, J., Sun, Y., Li, C., Wu, W., Jin, L., Yang, Z., Ni, B., Gao, P., Wang, P., Hua, Y., & Li, M.
Affiliations
  • 1Department of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, P.R. China.
  • 3Department of Electronic Engineering, Shanghai Jiao Tong University, Shanghai, P.R. China.
  • 6Department of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, P.R. China.
Venue
Cancer Research
Published
2018-12-13
Volume
78
Issue
24
Pages
6881-6889
ISSN
  • 0008-5472
  • 1538-7445
Cited by
190
References
7
Language
en
Funders
  • Shanghai Hospital Development Center (SHDC22015025)
  • National Key Research and Development Program of China (2017YFC0112800, 2017YFC0112905)
  • National Science Foundation of China (61502301)
  • Health Commission of Shanghai (2018ZHYL0103)
  • STCSM (17511105401, 18DZ2270700)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review